BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36006505)

  • 1. Comparison of pulmonary function changes between patients receiving neoadjuvant chemotherapy and chemoradiotherapy prior to minimally invasive esophagectomy: a randomized and controlled trial.
    Chen X; Du M; Tang H; Wang H; Fang Y; Lin M; Yin J; Tan L; Shen Y
    Langenbecks Arch Surg; 2022 Nov; 407(7):2673-2680. PubMed ID: 36006505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN
    JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of tidal volume on pulmonary complications following minimally invasive esophagectomy: a randomized and controlled study.
    Shen Y; Zhong M; Wu W; Wang H; Feng M; Tan L; Wang Q
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1267-73; discussion 1273-4. PubMed ID: 23993028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors of Cervical Anastomotic Leakage after McKeown Minimally Invasive Esophagectomy: Focus on Preoperative and Intraoperative Lung Function.
    Gao W; Wang M; Su P; Zhang F; Huang C; Tian Z
    Ann Thorac Cardiovasc Surg; 2021 Apr; 27(2):75-83. PubMed ID: 33087661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma.
    Ma S; Yan T; Liu D; Wang K; Wang J; Song J; Wang T; He W; Bai J; Jin L; Chen X
    Thorac Cancer; 2018 Feb; 9(2):310-315. PubMed ID: 29319236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
    Chen D; Wang W; Mo J; Ren Q; Miao H; Chen Y; Wen Z
    BMC Cancer; 2021 Feb; 21(1):145. PubMed ID: 33563244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.
    Warner S; Chang YH; Paripati H; Ross H; Ashman J; Harold K; Day R; Stucky CC; Rule W; Jaroszewski D
    Ann Thorac Surg; 2014 Feb; 97(2):439-45. PubMed ID: 24266955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study.
    Liu G; Han Y; Peng L; Wang K; Fan Y
    J Cardiothorac Surg; 2019 May; 14(1):97. PubMed ID: 31138245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life following neoadjuvant chemoradiotherapy versus perioperative chemotherapy and esophagectomy for esophageal cancer: a European multicenter study.
    Schuring N; Markar SR; Hagens ERC; Jezerskyte E; Sprangers MAG; Lagergren P; Johar A; Gisbertz SS; van Berge Henegouwen MI;
    Dis Esophagus; 2023 Mar; 36(4):. PubMed ID: 36241253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.
    Zahoor H; Luketich JD; Levy RM; Awais O; Winger DG; Gibson MK; Nason KS
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):538-47. PubMed ID: 25454907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Neoadjuvant Chemotherapy on Short-term Outcomes After Minimally Invasive Esophagectomy for Esophageal Cancer.
    Nomoto D; Yoshida N; Akiyama T; Kiyozumi Y; Eto K; Hiyoshi Y; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Miyamoto Y; Baba H
    Anticancer Res; 2019 Jan; 39(1):471-475. PubMed ID: 30591497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage minimally invasive esophagectomy after definitive chemoradiotherapy for esophageal cancer can improve postoperative complications compared with salvage open esophagectomy.
    Ishiyama K; Oguma J; Kubo K; Kanematsu K; Kurita D; Daiko H
    Surg Endosc; 2022 May; 36(5):3504-3510. PubMed ID: 34642795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer.
    Elliott JA; O'Byrne L; Foley G; Murphy CF; Doyle SL; King S; Guinan EM; Ravi N; Reynolds JV
    Br J Surg; 2019 Sep; 106(10):1341-1351. PubMed ID: 31282584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.
    Spector R; Zheng Y; Yeap BY; Wee JO; Lebenthal A; Swanson SJ; Marchosky DE; Enzinger PC; Mamon HJ; Lerut A; Odze R; Srivastava A; Agoston AT; Tippayawang M; Bueno R;
    Semin Thorac Cardiovasc Surg; 2015; 27(2):205-15. PubMed ID: 26686448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of minimally invasive esophagectomy after neoadjuvant chemoradiation.
    Bakhos C; Oyasiji T; Elmadhun N; Kent M; Gangadharan S; Critchlow J; Fabian T
    J Laparoendosc Adv Surg Tech A; 2014 Oct; 24(10):688-92. PubMed ID: 25180663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Neoadjuvant Radiation Therapy Contribute to the Incidence of Pulmonary Complications Following Esophagectomy for Malignant Neoplasm?
    Beier MA; Greenbaum AA; Kangas-Dick AW; August DA
    Am Surg; 2023 Nov; 89(11):4780-4788. PubMed ID: 36286615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary diffusion capacity predicts major complications after esophagectomy for patients with esophageal cancer.
    Goense L; Meziani J; Bülbül M; Braithwaite SA; van Hillegersberg R; Ruurda JP
    Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30239639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.